6533b7d3fe1ef96bd1260bfd
RESEARCH PRODUCT
208: Impact of posaconazole (POS) vs fluconazole (FLU) on cyclosporine (CsA) and tacrolimus (TAC) dosing in hematopoietic stem cell transplant (HSCT) recipients with graft-vs-host disease (GVHD)
T. BrundageHernando PatinoAmelia LangstonJeffrey H. LiptonAndrew J. Ullmannsubject
TransplantationPosaconazolebusiness.industryHematopoietic stem cellHematologybiochemical phenomena metabolism and nutritionbacterial infections and mycosesTacrolimusmedicine.anatomical_structureImmunologyMedicineDosingbusinessHost diseaseFluconazolemedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2007-02-01 | Biology of Blood and Marrow Transplantation |